about
Replication-initiator protein (UL9) of the herpes simplex virus 1 binds NFB42 and is degraded via the ubiquitin-proteasome pathwayAcyclovir in first attacks of genital herpes and prevention of recurrencesTowards an understanding of the herpes simplex virus type 1 latency-reactivation cycleRelative and seasonal incidences of the sexually transmitted diseases. A two-year statistical review.Herpesvirus hominis antibodies among children and young adults in IbadanHerpesvirus hominis type 2 infection in Ibadan. Problem of non-venereal transmissionEffect of treatment with 1-beta-D-arabinofuranosylthymine of experimental encephalitis induced by herpes simplex virus in miceThe locus encompassing the latency-associated transcript of herpes simplex virus type 1 interferes with and delays interferon expression in productively infected neuroblastoma cells and trigeminal Ganglia of acutely infected mice.Serum antibodies to herpes simplex virus type 1 during active oral herpes infectionEffect of prostaglandins and cyclic adenosine 3',5'-monophosphate modulators on herpes simplex virus growth and interferon response in human cells.Role of specific cytotoxic lymphocytes in cellular immunity against murine cytomegalovirusIdentification of a novel herpes simplex virus type 1 transcript and protein (AL3) expressed during latency.The epidemiology of herpes simplex types 1 and 2 infection of the genital tract in Edinburgh 1978-1991.Role for cell-mediated immunity in the resistance of mice to subcutaneous herpes simplex virus infection.The herpes simplex virus type 1 locus that encodes the latency-associated transcript enhances the frequency of encephalitis in male BALB/c miceProtection from oral herpes simplex virus infection by a nucleic acid-free virus vaccine.Cellular and humoral immune responses to herpes simplex virus during and after primary gingivostomatitisIncreased incidence of skin infections in atopy: evidence for an antigen-specific homing defect?Herpesvirus hominis infection in newborn mice: comparison of the therapeutic efficacy of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosyladenine.Prospective double-blind evaluation of topical adenine arabinoside in male herpes progenitalisHerpes simplex virus type 1 and bovine herpesvirus 1 latency.The modulation of phosphatase expression impacts the proliferation efficiency of HSV-1 in infected astrocytes.Antibodies to Herpesvirus hominis types 1 and 2 in malnourished Nigerian children.First episodes of genital herpes in a Swedish STD population: a study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing and specific serology.Social support and socioeconomic status interact to predict Epstein-Barr virus latency in women awaiting diagnosis or newly diagnosed with breast cancer.Latent herpes simplex virus type 1 gene expression in ganglia innervating the human gastrointestinal tract.Kinetics and genetics of herpes simplex virus-induced antibody formation in mice.Alteration of mortality and pathogenesis of three experimental Herpesvirus hominis infections of mice with adenine arabinoside 5'-monophosphate, adenine arabinoside, and phosphonoacetic acidTherapy of experimental herpes simplex encephalitis with aciclovir in miceRadiculomyelopathy associated with herpes simplex genitalis treated with adenosine arabinosideHerpes simplex virus (HSV)-specific human T-cell clones recognize HSV glycoprotein D expressed by a recombinant vaccinia virus.X-linked resistance of mice to high doses of herpes simplex virus type 2 correlates with early interferon productionHLA-restricted T lymphocyte-mediated cytotoxicity against herpes simplex virus-infected cells in humans.Loss of mandibular lymph node integrity is associated with an increase in sensitivity to HSV-1 infection in CD118-deficient miceEnumeration of viral antigen-reactive helper T lymphocytes in human peripheral blood by limiting dilution for analysis of viral antigen-reactive T-cell pools in virus-seropositive and virus-seronegative individuals.Two outbreaks of herpes simplex virus type 1 nosocomial infection among newbornsDetection of asymptomatic initial herpes simplex virus (HSV) infections in animals immunized with subunit HSV glycoprotein vaccines.Detection of genital herpes simplex infections by a tissue culture-fluorescent-antibody technique with biotin-avidin.Two small RNAs encoded within the first 1.5 kilobases of the herpes simplex virus type 1 latency-associated transcript can inhibit productive infection and cooperate to inhibit apoptosis.Use of biological characteristics to type Herpesvirus hominis types 1 and 2 in diagnostic laboratories.
P2860
Q24680651-4E396FAC-2B0E-4B78-8B45-5059661A30EFQ33583052-2A611461-55A2-4E6E-976C-01AA10FEF7F1Q33654414-19FC41CB-6CA3-417E-BF63-7A10CBEFD715Q33656174-676CD270-E405-4847-BD5B-C8E35697832FQ33656266-EB7766BE-55FB-434C-A9B7-ECAF2F31BABEQ33657169-FDFC85AD-73D8-46B5-805F-3223C9792838Q33723014-676CDA00-C5EB-46AE-A205-20C00EEBB4E7Q33780491-4CE31B19-02ED-4E70-B7DF-96258361A679Q33897914-2ED87A9C-2FA0-4CF2-B250-54A1125106E1Q33898085-522D52A5-24FF-4EFB-9D39-E164AA4C5474Q33900303-D7C39788-97EB-4391-8A80-CACA0B70F681Q33922876-588723A7-D31A-4371-B72D-2A5B1C27C657Q33934554-FD5C1B35-7F07-4C1C-B532-50E1005C0F3AQ34123889-FA530850-85BE-4682-8D92-61821C70E642Q34123978-D18BA356-022F-4D7C-B800-3428398805ACQ34410407-98A5AEAA-69C4-429F-98D3-7F654A584FB2Q34460442-09DBFFA9-4881-4619-861C-8082E8928797Q34585480-E4114684-C89C-4C95-A51D-14E9F9EF9DDDQ34927859-6B281617-BA31-4E3E-8044-9E324EEEE141Q34958709-D6E6793B-A61C-459A-A7D6-4220C471180BQ35044114-BF1EC58F-ED58-4BA0-9DA0-F425AF46A2E0Q35048616-A26D05AB-01E0-405C-BCA1-993B82FEAB4FQ35114805-CF666312-4892-4118-AE23-E5F38891D2EAQ35528603-D0ECBAF0-7BFE-4CE1-BB35-BE278DD41582Q35663693-3513A3BC-8545-4511-B5F1-D9FCB07586A6Q35884349-95C524E2-4B9B-41A4-9E76-8FAA480D6EE8Q36341079-A22451B5-7DF4-490E-AD3D-96E387F899DAQ36465468-077559B7-5DA8-4B65-9B60-3665CAAC84BBQ36480860-E30A946C-102A-40D6-B9E5-8AFAA0A2956FQ36704646-3A376CB2-072B-4B11-8D2A-6845BE853CB8Q36865265-55EF566F-E744-458C-B095-B810C79CCA3DQ37102567-00F23336-5479-4A2B-AF95-D1BD89902490Q37110823-C3E0D6CE-1D73-4F4D-B09B-DEDDCA8380F7Q37120677-138A3196-5949-4684-B9A3-9FD5DD51F017Q37160936-883951F0-E65D-4378-A5B0-8B75EAA348AEQ37207155-763C619A-6B23-4F25-A43B-AA45A62B4294Q37224689-3D05E3E3-CE09-416B-A034-4231F97E9A90Q37302802-48357C0D-49EF-44C6-8B2A-95BEF6B7ED1FQ37333965-22D5BE48-E645-46D2-8DBD-E4BB3A0EB029Q37343998-38585F9C-021D-4332-841B-E728F32E29C1
P2860
description
1973 nî lūn-bûn
@nan
1973年の論文
@ja
1973年学术文章
@wuu
1973年学术文章
@zh-cn
1973年学术文章
@zh-hans
1973年学术文章
@zh-my
1973年学术文章
@zh-sg
1973年學術文章
@yue
1973年學術文章
@zh
1973年學術文章
@zh-hant
name
Infection with herpes-simplex viruses 1 and 2. 3.
@en
Infection with herpes-simplex viruses 1 and 2. 3.
@nl
type
label
Infection with herpes-simplex viruses 1 and 2. 3.
@en
Infection with herpes-simplex viruses 1 and 2. 3.
@nl
prefLabel
Infection with herpes-simplex viruses 1 and 2. 3.
@en
Infection with herpes-simplex viruses 1 and 2. 3.
@nl
P1476
Infection with herpes-simplex viruses 1 and 2. 3.
@en
P2093
Nahmias AJ
P304
P356
10.1056/NEJM197310112891505
P407
P577
1973-10-01T00:00:00Z